Speaker A
Foreign, thank you for coming in today. We're very excited to have you. My name is Ziad, and I will be your interviewer today.
Bain Associate Consultant leads a Botox migraine market entry case interview, covering market sizing, financials, and risks.
Key Takeaways
- Structured frameworks are essential for tackling consulting case interviews.
- Market sizing requires breaking down the problem into population, prevalence, usage frequency, and pricing.
- Financial analysis must consider both revenue potential and cost implications.
- Risk assessment should include operational capabilities and regulatory environment.
- Clear communication and confirming assumptions with the interviewer are critical.
What the video covers
- The video features a Bain Associate Consultant conducting a consulting case interview focused on Botox's potential entry into the migraine treatment market.
- The case involves assessing the viability of launching a Botox injection product currently in clinical trials awaiting FDA approval.
- Key factors analyzed include the migraine market size, financial implications such as pricing and costs, and potential risks including logistical and regulatory challenges.
- The candidate outlines a structured approach to market sizing based on U.S. population, migraine prevalence, injection frequency, and pricing assumptions.
- Financial considerations include revenue projections, pricing strategy, customer willingness to pay, and cost factors like R&D and clinical trials.
- Risks discussed cover supply chain capabilities, workforce expertise, alignment with Botox’s portfolio, FDA approval barriers, and insurance reimbursement issues.
- The candidate uses rough estimates and assumptions to calculate a $19 billion total migraine injection market in the U.S. and a $5.7 billion potential Botox market share.
- The interview emphasizes a methodical, hypothesis-driven approach to problem solving in consulting case interviews.
- The video provides insight into how to structure and communicate a consulting case analysis effectively.
Chapters
- 00:00Introduction and Interviewer Greeting
- 01:02Case Overview: Botox Migraine Market Entry
- 02:01Product Details and Benefits
- 03:03Framework for Analysis: Market, Financials, Risks
- 04:18Risk Assessment: Logistical and Regulatory
- 05:15Starting Market Sizing Discussion
- 07:14Market Sizing Calculations and Assumptions
- 09:35Pricing and Market Share Estimation
Full Transcript — Download SRT & Markdown
Speaker A
Awesome, great. I'm super excited to be here. I am Maria Vagyan.
Speaker A
Awesome, so, um, do you want to just dive straight into the case?
Speaker A
Yeah, I'm ready whenever you are.
Speaker A
Okay, let's do it. So, for today's case, you actually have a maker of Botox that is considering expanding into the migraine market, and they've already begun clinical trials in this area. The product is expected to receive FDA approval at the end of the year, and your team has been hired to assess the viability of the product launch. So essentially, the question is, how would you determine if the Botox company should enter the migraine market?
Speaker A
Okay, awesome. Thank you for sharing that information. So just before I get started, I want to make sure I correctly understand the client here is Botox, and they are considering expanding into the migraine market, and the product they're working with is going through the trial process now, waiting for FDA approval, and our main goal here is to figure out whether or not it's viable to enter the migraine market.
Speaker A
That's correct.
Speaker A
Okay, awesome. So before we get started, I just wanted a little bit more information about the product to know exactly what it looks like.
Speaker A
Sure. Um, so what I know is that the product is basically an injection that is given every two months, and it offers similar efficacy to other market options without any side effects. And as a benefit, it does have some skincare benefits to it.
Speaker A
Okay, awesome. As a person who loves skincare, that's amazing. I feel like that's all the information I need. So is it okay if I take a couple of moments to brainstorm my thoughts?
Speaker A
Absolutely.
Speaker A
Awesome, thank you.
Speaker A
Okay, great. So after looking at the situation at hand, in order to figure out whether or not Botox should enter the migraine market, there are three main factors I'm thinking about: the migraine market, financial implications, and just overall risks.
Speaker A
So under the migraine market, I think it would be really beneficial to understand what the size of the migraine market looks like and what consumer demand is, also diving into how fast it's growing, if it's stagnant or shrinking, just like the overall market growth. And then I think it'd be really beneficial to understand what other treatments are out there and what potential competition would look like to see what Botox's market share could be.
Speaker A
So second, diving into the financial implications, there's kind of two sides I think would be helpful: the revenues and costs. So under revenues, I think it would be great to understand what the competitors are pricing injections for to determine how Botox should price it. It'd be also helpful to understand what our customers' elasticity is and their willingness to pay to figure out a good price, and then doing a little bit more analysis into what number of units sold could look like and how cannibalization of other Botox products would affect this law.
Speaker A
And then on the cost side, it would be helpful to understand what initial investments would be needed, looking at the research and development, maybe potential clinical trial costs, and then what ongoing costs there may be for this injection.
Speaker A
And third, the risks. I see two main areas within the risks: a logistical aspect and then more regulatory. So in the logistics, I think something to keep note of is figuring out whether or not Botox has the capabilities to add additional supply chain distribution centers or production facilities. Maybe diving a little bit into what our administrative or workforce expertise and skills look like to see if it's capable for us to launch such a big product.
Speaker A
And then lastly, under logistical risks, kind of figuring out if this injection matches with Botox's mission and portfolio of their other products.
Speaker A
And then lastly, under regulatory risks, you had mentioned that we're in the clinical trial process looking for FDA approval, so diving into what the barriers to entry would be, looking at specifically the FDA approval, maybe if any patents are needed, what progressing clinical trials look like.
Speaker A
So after assessing the overall migraine market, financial implications, and risks, I think we would have a good understanding if this is a viable entry or not. But looking at it, I think it'd be beneficial to start off with the market as a whole and see if that's attractive or not. Does that sound good?
Speaker A
Yeah, let's do that. Actually, I think that's a good place to start. Maybe we can go by how big do you think this market is in the first place?
Speaker A
Okay, perfect. So just to make sure, you want me to market size the overall Botox injection market? Is that specifically for the US?
Speaker A
That's correct, just the US.
Speaker A
Okay, perfect. Is it okay if I take a couple of moments to brainstorm my thoughts?
Speaker A
Absolutely, awesome.
Speaker A
Okay, perfect. So the way that I think about this is to estimate the size of the Botox injection market, we should start off with the overall U.S. population, then dive into the percentage of people who suffer from headaches, and then the percentage of people who have headaches that are bad enough that they would need these injections. Then by doing those calculations, we can get the total size of the total number of patients that we'd be working with.
Speaker A
And then from there, I'm thinking I could estimate the number of injections per patient and put a price tag to that to figure out the overall market size for injections. And then we're looking specifically at Botox's share, so then applying what our potential market share would look like to get the overall Botox market size for injections. Does that sound like a good process?
Speaker A
Yeah, no, that's a good approach.
Speaker A
Okay, awesome. So I'm just going to take a moment to put the math to that.
Speaker A
Okay, awesome. So if we start off with the US population of 320 million, I would say about, thinking from personal experience of my friends, like one in every five, I feel like, get headaches. So we could say about 20% of people suffer from headaches.
Speaker A
And then out of those 20%, I'd say like one in four people have headaches that are so bad that they would need some sort of migraine injection treatment. So let's take 25% of that. So 20% of 320 million is 64 million, and then a fourth of 64 million is going to be 16 million. So that's the number of patients that may be needing an injection.
Speaker A
Next, I'm going to think about how many injections a patient would need. I think you mentioned that these injections are needed every two months, so a patient would need it six times a year.
Speaker A
And then next, I want to think about what a potential price would be. So I personally have not had any Botox; I'm only 21, but I'm thinking that it ranges quite a bit from very cheap options to more expensive. Off the gun, I think about 200 is a pretty fair price tag to put on it.
Speaker A
I think so, that's a good price.
Speaker A
Okay, great. So I'll take the 16 million number of patients times six injections a year times two hundred dollars per injection, and I'll just take a moment to crank out that math really quickly. 16 times 6 is 96, times 200 is going to be 19.2 billion dollars. So I'm getting 19.2 billion dollars for the total market. But we're looking specifically at Botox. Botox, I know, has like a really big name. They're a well-known company, so I'm assuming they have a pretty high market share. I think around 30% is a good bet. Does that sound like a good number?
Speaker A
I would say so.
Speaker A
Yeah, okay, great. So I'm going to take 30%, and is it okay if I round that 19.2 billion to 19 billion?
Speaker A
Sure.
Speaker A
Okay, great. So 30% of 19 billion is going to be, I know 19 times 3 is 57, so 30% of 19 will be 5.7 billion. So I'm getting a total number of 5.7 billion dollars for the U.S. Botox injection market.
Speaker A
Great. So looking at that number, I'm trying to figure out whether or not it's attractive or not. It seems like a pretty big number, but I think to really determine if the market is attractive or not, we could look at what potential growth looks like or what the competitive landscape is. Do we have any information about either of those?
Speaker A
Yeah, so we have.
Speaker A
name keep that same name I know that Botox has a very specific connotation to it that it's cosmetic kind of controversial sometimes but we're not servicing a cosmetic product so it might turn some patients away because ours is a migraine
Speaker A
injection not a cosmetic injection but then if we were to use a different name there's the possibility if there being a lack of Market traction because you have to redo all the marketing and branding since Botox already has a big
Speaker A
name so if you were to use a different one A little bit harder to get some traction there so is The Branding side next we look under cannibalization so Botox already has some pre-existing products of course they have some
Speaker A
injections like lip injections I think so I'm thinking that if we're launching a new product at a pretty similar price range maybe lower it might cannibalize some of botox's pre-existing products stock is a concern to look at but I'm
Speaker A
thinking that if we do a little bit more investigation into the regulatory process or other mechanisms to kind of keep the market separate that could be a potential mitigation to it and then lastly is the patient concerns I'm thinking that with patient concerns
Speaker A
I know that I personally am very scared of shots so there may be other patients out there that are a little bit adverse to injectable therapies especially when there might be oral remedies like other like Tylenol or Advil or other
Speaker A
things that they could take to get rid of their migraine another patient concern to think about is that they the injection is still being approved by the FDA right so they may be a little bit averse to using a product that has
Speaker A
just been approved and may be looking to see more research or more trials in the future and then the last concern with patients is that insurance companies may not necessarily pay for the botox injection so we may have to look a little bit more
Speaker A
with insurance companies to make sure that this is something that they will put onto their plan awesome um all sounds like good risks to take into account so CEO of the company walks in and wants a 30 second recommendation
Speaker A
what do you say awesome um yeah I would say this sounds like a very viable opportunity it seems like the market is very attractive we did calculations and saw that the market is about 5.7 billion dollars that Botox
Speaker A
could tap into which seems very attractive since the market is stagnant it's not super saturated just as a potential risk though since we're still in the clinical trials and FDA process it's very dependent on making it past that so just continuing to do the
Speaker A
clinical trials working with insurance companies to make sure it can get on the plan and marketing the product in a way that alleviates patient concerns for like using the product in the future I feel like are the best ways to go but
Speaker A
yeah overall it seems like a great opportunity awesome well thank you so much for the time and yeah I thought I thought that that was a that was a case awesome thank you that's exactly how a mock interview goes
Speaker A
when it comes to Ria's performance I thought that she did fantastic everything from the beginning all the way to the end when it came to the prompt she asked thoughtful clarifying questions and she made sure that she understood the
Speaker A
objective when it came to the framework this was a combination of a market entry and a market sizing case and I think that she did a good job at structuring both Frameworks on the market entry side she explained that we needed to look at
Speaker A
the market the financials and the risks when it came to the market sizing she laid out a very good approach that was structured and clear on how she would calculate the market size on the analysis side she did great when
Speaker A
it came to the math all of her numbers were sharp and her methodology was very clear and she was able to explain all of the numbers to me finally when it came to the brainstorming she was able to put
Speaker A
everything into different buckets and she remained structured and poised throughout the entire process so overall I thought that she did very well and I would definitely accelerate her to the next round foreign [Music]
Topics:consulting case interviewBain Associate ConsultantBotoxmigraine marketmarket sizingfinancial analysisFDA approvalclinical trialsrisk assessmentcase interview preparation
